Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53

被引:4
作者
Chène, P [1 ]
机构
[1] Novartis, Dept Oncol, CH-4002 Basel, Switzerland
关键词
oligomerisation; p53; tetramerisation;
D O I
10.1006/jmbi.1999.2734
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 proteins from human, murine and Xenopus laevis are tetrameric. Previous work has shown that both human and murine p53 can form heterotetramers. However, despite a very high level of sequence homology at their tetramerisation domain, the human and the X. laevis p53 do not form heterooligomers. It is shown here that when inserted in the human p53 protein, the X. laevis tetramerisation domain is able to oligomerise with the human one. This indicates that the inability of X. laevis p53 to heterooligomerise with human p53 is due to another structural difference. The use of N and C-truncated X. laevis p53 proteins reveals that the deletion of the N terminus favours from the heterooligomerisation between the human and the X. laevis p53. The oligomerisation of the X. laevis p53 with the human protein is also enhanced when the N terminus of the X. laevis p53 is replaced by the human one. Altogether these data suggest that the N terminus of p53 influences the oligomerisation. (C) 1999 Academic Press.
引用
收藏
页码:883 / 890
页数:8
相关论文
共 19 条
[1]   P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES [J].
CAELLES, C ;
HELMBERG, A ;
KARIN, M .
NATURE, 1994, 370 (6486) :220-223
[2]   In vitro structure-function analysis of the beta-strand 326-333 of human p53 [J].
Chene, P ;
Mittl, P ;
Grutter, M .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (04) :873-881
[3]   HIGH-RESOLUTION STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTIDIMENSIONAL NMR [J].
CLORE, GM ;
OMICHINSKI, JG ;
SAKAGUCHI, K ;
ZAMBRANO, N ;
SAKAMOTO, H ;
APPELLA, E ;
GRONENBORN, AM .
SCIENCE, 1994, 265 (5170) :386-391
[4]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[5]   CONFORMATIONAL SHIFTS PROPAGATE FROM THE OLIGOMERIZATION DOMAIN OF P53 TO ITS TETRAMERIC DNA-BINDING DOMAIN AND RESTORE DNA-BINDING TO SELECT P53 MUTANTS [J].
HALAZONETIS, TD ;
KANDIL, AN .
EMBO JOURNAL, 1993, 12 (13) :5057-5064
[6]   Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies [J].
Harris, CC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) :1442-1455
[7]   INDUCTION OF APOPTOSIS IN HELA-CELLS BY TRANS-ACTIVATION-DEFICIENT P53 [J].
HAUPT, Y ;
ROWAN, S ;
SHAULIAN, E ;
VOUSDEN, KH ;
OREN, M .
GENES & DEVELOPMENT, 1995, 9 (17) :2170-2183
[8]  
HOEVER M, 1994, ONCOGENE, V9, P109
[9]   REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
CELL, 1992, 71 (05) :875-886
[10]  
Jayaraman L, 1997, METHOD ENZYMOL, V283, P245